Skip to main content

Peer Review reports

From: Effects on quality of life, anti-cancer responses, breast conserving surgery and survival with neoadjuvant docetaxel: a randomised study of sequential weekly versus three-weekly docetaxel following neoadjuvant doxorubicin and cyclophosphamide in women with primary breast cancer

Original Submission
23 Apr 2010 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
27 Nov 2010 Reviewed Reviewer Report - Volkmar Muller
14 Mar 2011 Author responded Author comments - Mark Aloysius
Resubmission - Version 3
14 Mar 2011 Submitted Manuscript version 3
18 May 2011 Editorially accepted
18 May 2011 Article published 10.1186/1471-2407-11-179

You can find further information about peer review here.

Back to article page